Brown Advisory
FLGT icon

Brown Advisory’s Fulgent Genetics FLGT Stock Holding History

Brown Advisory’s Portfolio FLGT Stock Details FLGT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-14,469
Closed -$86K – 1112
2019
Q1 		$86K Hold
14,469
– – ﹤0.01% 1289
2018
Q4 		$46K Buy
+14,469
New +$50.8K ﹤0.01% 1225

Other funds holding FLGT

OWIM
Old West Investment Management Los Angeles, California $923M AUM 112.31% 1-Year Est. Return
MA
Mutual Advisors Omaha, Nebraska $4.67B AUM 17.48% 1-Year Est. Return
EIM
Essex Investment Management Boston, Massachusetts $632M AUM 95.36% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
RA
Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Carson Wealth (CWM LLC)
Carson Wealth (CWM LLC) Omaha, Nebraska $38.1B AUM 19.66% 1-Year Est. Return

Brown Advisory's FLGT Position: Q2 2019 in Review

Brown Advisory sold out of Fulgent Genetics (FLGT) in Q2 2019, closing a stake of 14,469 shares — an estimated $86K sold.

Brown Advisory first reported a position in FLGT in Q4 2018 and held it in 2 quarters. The position peaked at $86K in Q1 2019. 14 funds tracked by Wall St. Rank hold FLGT as of Q2 2019.

  • Brown Advisory reported no remaining Fulgent Genetics position as of Q2 2019 after selling out during the quarter.
  • Brown Advisory sold 14,469 Fulgent Genetics shares in Q2 2019, an estimated $86K.
  • Brown Advisory first reported a position in Fulgent Genetics in Q4 2018 and held it in 2 quarters.
  • Brown Advisory's Fulgent Genetics position peaked at $86K in Q1 2019.
  • 14 funds tracked by Wall St. Rank held Fulgent Genetics as of Q2 2019.

Based on Brown Advisory's 13F filing for Q2 2019, filed 12 Aug 2019.